Molybdopterin synthase

Last updated
Molybdopterin synthase
Identifiers
EC no. 2.8.1.12
Databases
IntEnz IntEnz view
BRENDA BRENDA entry
ExPASy NiceZyme view
KEGG KEGG entry
MetaCyc metabolic pathway
PRIAM profile
PDB structures RCSB PDB PDBe PDBsum
Search
PMC articles
PubMed articles
NCBI proteins

Molybdopterin synthase (EC 2.8.1.12, MPT synthase) is an enzyme required to synthesize molybdopterin (MPT) from precursor Z (now known as cyclic pyranopterin monophosphate). [1] [2] Molydopterin is subsequently complexed with molybdenum to form molybdenum cofactor (MoCo). MPT synthase catalyses the following chemical reaction:

Contents

precursor Z + 2 [molybdopterin-synthase sulfur-carrier protein]-Gly-NH-CH2-C(O)SH + H2O molybdopterin + 2 molybdopterin-synthase sulfur-carrier protein

Molybdopterin synthase is heterodimeric and coded for by the MOCS2 gene. [3] Genetic deficiencies of enzymes such as MPT synthase, which are involved in MoCo biosynthesis, lead to MoCo deficiency, a rare disease that results in severe neurological abnormalities. [4] [5] [6] [7]

Structure

Human MPT Synthase crystal structure. Small subunits are shown in cyan and green, with their C-terminus colored orange. Large subunits are shown in yellow and magenta. MPT Synthase Human Crystal Structure.png
Human MPT Synthase crystal structure. Small subunits are shown in cyan and green, with their C-terminus colored orange. Large subunits are shown in yellow and magenta.

The high resolution crystal structure of MPT synthase shows the enzyme has a heterotetrametric structure composed of two small subunits (MoaD in prokaryotes) and two large subunits (MoaE in prokaryotes) with the small subunits at opposite ends of a central large subunit dimer. [1] [4] [5] The C-terminus of each small subunit is inserted into a large subunit to form the active site. [4] In the enzyme's activated form the C-terminus is present as a thiocarboxylate, which acts as the sulfur donor to precursor Z in MoCo biosynthesis. [4] As a result, the active site of the enzyme must be in close proximity to the C-terminus of the small subunit (i.e. MoaD in prokaryotes). The high resolution crystal structure of the enzyme also reveals the presence of a binding pocket for the terminal phosphate of molybdopterin and suggests a possible binding site for the pterin moiety present both in precursor Z and molybdopterin. [8]

The structural similarity between ubiquitin and the small subunit of MPT synthase hints at the evolutionary relationship of the MoCo biosynthesis pathway and the ubiquitin dependent protein degradation pathway. [4] [9] Specifically, the small subunit MoaD in prokaryotes is a sequence homolog of Urm1, indicating that MPT synthase probably shares a common ancestor with ubiquitin. [9]

Mechanism

Prokaryote MPT Synthase Reaction Mechanism MPT Synthase Reaction Mechanism.png
Prokaryote MPT Synthase Reaction Mechanism

The biosynthesis of MoCo is an old and evolutionary conserved pathway present in eukaryotes, eubacteria, and archea, which can be divided into three major steps. [4] The first step involves the conversion of a guanosine nucleotide into precursor Z. [4] [10] In the following step, MPT synthase catalyzes the incorporation of the dithiolene moiety  to precursor Z, which converts it to molybdopterin. [4] More specifically, this interconversion involves the opening of the cyclic phosphate ring of precursor Z, and the addition of two side chain sulfhydryl groups. [10] E-coli MPT synthase is activated by the formation of a thiocarboxylate group at the second glycine of its C-terminal Gly-Gly motif, which serves as the sulfur donor for the formation of the diothiolene group in MPT. [5] [11] That is, the mechanism on MPT synthase depends on the interconversion between the activated form of MoaD with the thiocarboxylate group and the MoaE protein [8] In the final step of MoCo biosynthesis, molybendum is incorporated to MPT by the two-domain protein gephyrin. [5] [6] MPT synthase sulfurylase recharges MPT synthase with a sulfur atom after each catalytic cycle. [9]

Biological function

MPT synthase is involved in the biosynthesis of MoCo, which is essential for the activity of enzymes like xanthine dehydrogenase, aldehyde oxidase, and sulfite oxidase in humans. [5] MoCo containing enzymes typically catalyze the net transfer of an oxygen atom to and from  their substrates in a two electron redox reaction. [4]

Disease relevance

MoCo deficiency in humans results in the combined deficiency of the MoCo-containing enzymes: sulfite oxidase, xanthine oxidase, and aldehyde oxidase. [4] [5] [7] Symptoms of MoCo deficiency are linked to the accumulation of toxic metabolites caused by the reduced activity of these molybdoenzymes, especially sulfite oxidase. [4] Genetic defects in MoCo biosynthesis lead to MoCo deficiency. [4] These genetic defects affect the formation of precursor Z (known as group A MoCo deficiency) or the conversion of precursor Z to MoCo by MPT synthase (known as group B MoCo deficiency). [7] [12] MOCS1 is defective for group A (the majority of patients), and encodes two enzymes involved in the formation of precursor Z. [7] [12] MOCS2 is defective for group B and encodes the small and large subunits of MPT synthase. [7] [12] Groups A and B of deficiency show an identical phenotype, characterized by neonatal seizures, attenuated brain growth, dislocated ocular lenses, feeding difficulties, among other neurological symptoms. [4] [5] [6] [7] [12] This rare but severe deficiency is an autosomal recessive trait, which usually results in early childhood death as there is currently no available treatment. [4] [5] [6] [7]

Related Research Articles

<span class="mw-page-title-main">6-Pyruvoyltetrahydropterin synthase deficiency</span> Medical condition

6-Pyruvoyltetrahydropterin synthase deficiency is an autosomal recessive disorder that causes malignant hyperphenylalaninemia due to tetrahydrobiopterin deficiency. It is a recessive disorder that is accompanied by hyperphenylalaninemia. Commonly reported symptoms are initial truncal hypotonia, subsequent appendicular hypertonia, bradykinesia, cogwheel rigidity, generalized dystonia, and marked diurnal fluctuation. Other reported clinical features include difficulty in swallowing, oculogyric crises, somnolence, irritability, hyperthermia, and seizures. Chorea, athetosis, hypersalivation, rash with eczema, and sudden death have also been reported. Patients with mild phenotypes may deteriorate if given folate antagonists such as methotrexate, which can interfere with a salvage pathway through which dihydrobiopterin is converted into tetrahydrobiopterin via dihydrofolate reductase. Treatment options include substitution with neurotransmitter precursors, monoamine oxidase inhibitors, and tetrahydrobiopterin. Response to treatment is variable and the long-term and functional outcome is unknown. To provide a basis for improving the understanding of the epidemiology, genotype–phenotype correlation and outcome of these diseases, their impact on the quality of life of patients, and for evaluating diagnostic and therapeutic strategies a patient registry was established by the noncommercial International Working Group on Neurotransmitter Related Disorders (iNTD).

DMSO reductase is a molybdenum-containing enzyme that catalyzes reduction of dimethyl sulfoxide (DMSO) to dimethyl sulfide (DMS). This enzyme serves as the terminal reductase under anaerobic conditions in some bacteria, with DMSO being the terminal electron acceptor. During the course of the reaction, the oxygen atom in DMSO is transferred to molybdenum, and then reduced to water.

<span class="mw-page-title-main">Molybdopterin</span> Heterocyclic ligand that can complex molybdenum to form a Mo-cofactor

Molybdopterins are a class of cofactors found in most molybdenum-containing and all tungsten-containing enzymes. Synonyms for molybdopterin are: MPT and pyranopterin-dithiolate. The nomenclature for this biomolecule can be confusing: Molybdopterin itself contains no molybdenum; rather, this is the name of the ligand that will bind the active metal. After molybdopterin is eventually complexed with molybdenum, the complete ligand is usually called molybdenum cofactor.

<span class="mw-page-title-main">Sulfite oxidase</span>

Sulfite oxidase is an enzyme in the mitochondria of all eukaryotes, with exception of the yeasts. It oxidizes sulfite to sulfate and, via cytochrome c, transfers the electrons produced to the electron transport chain, allowing generation of ATP in oxidative phosphorylation. This is the last step in the metabolism of sulfur-containing compounds and the sulfate is excreted.

In enzymology, an ethylbenzene hydroxylase (EC 1.17.99.2) is an enzyme that catalyzes the chemical reaction

<span class="mw-page-title-main">MOCS1</span> Protein-coding gene in the species Homo sapiens

Molybdenum cofactor biosynthesis protein 1 is a protein that in humans and other animals, fungi, and cellular slime molds, is encoded by the MOCS1 gene.

<span class="mw-page-title-main">MOCS2</span> Protein-coding gene in the species Homo sapiens

Molybdenum cofactor synthesis protein 2A and molybdenum cofactor synthesis protein 2B are a pair of proteins that in humans are encoded from the same MOCS2 gene. These two proteins dimerize to form molybdopterin synthase.

<span class="mw-page-title-main">MOCS3</span> Protein-coding gene in the species Homo sapiens

Adenylyltransferase and sulfurtransferase MOCS3 is an enzyme that in humans is encoded by the MOCS3 gene.

Molybdenum cofactor deficiency is a rare human disease in which the absence of molybdopterin – and consequently its molybdenum complex, commonly called molybdenum cofactor – leads to accumulation of toxic levels of sulphite and neurological damage. Usually this leads to death within months of birth, due to the lack of active sulfite oxidase. Furthermore, a mutational block in molybdenum cofactor biosynthesis causes absence of enzyme activity of xanthine dehydrogenase/oxidase and aldehyde oxidase.

Radical SAM enzymes belong to a superfamily of enzymes that use an iron-sulfur cluster (4Fe-4S) to reductively cleave S-adenosyl-L-methionine (SAM) to generate a radical, usually a 5′-deoxyadenosyl radical (5'-dAdo), as a critical intermediate. These enzymes utilize this radical intermediate to perform diverse transformations, often to functionalize unactivated C-H bonds. Radical SAM enzymes are involved in cofactor biosynthesis, enzyme activation, peptide modification, post-transcriptional and post-translational modifications, metalloprotein cluster formation, tRNA modification, lipid metabolism, biosynthesis of antibiotics and natural products etc. The vast majority of known radical SAM enzymes belong to the radical SAM superfamily, and have a cysteine-rich motif that matches or resembles CxxxCxxC. Radical SAM enzymes comprise the largest superfamily of metal-containing enzymes.

Molybdenum cofactor cytidylyltransferase is an enzyme with systematic name CTP:molybdenum cofactor cytidylyltransferase. This enzyme catalyses the following chemical reaction:

Molybdenum cofactor guanylyltransferase is an enzyme with systematic name GTP:molybdenum cofactor guanylyltransferase. This enzyme catalyses the following chemical reaction:

Molybdopterin-synthase adenylyltransferase is an enzyme with systematic name ATP:molybdopterin-synthase adenylyltransferase. This enzyme catalyses the following chemical reaction

Molybdenum cofactor sulfurtransferase (EC 2.8.1.9, molybdenum cofactor sulfurase, ABA3, MoCo sulfurase, MoCo sulfurtransferase) is an enzyme with systematic name L-cysteine:molybdenum cofactor sulfurtransferase. This enzyme catalyses the following chemical reaction

Molybdopterin synthase sulfurtransferase is an enzyme with systematic name persulfurated L-cysteine desulfurase:(molybdopterin-synthase sulfur-carrier protein)-Gly-Gly sulfurtransferase. This enzyme catalyses the following chemical reaction

Molybdopterin molybdotransferase is an enzyme with systematic name adenylyl-molybdopterin:molybdate molybdate transferase (AMP-forming). This enzyme catalyses the following chemical reaction

Cyclic pyranopterin monophosphate synthase is an enzyme with systematic name GTP 8,9-lyase . This enzyme catalyses the following chemical reaction

<span class="mw-page-title-main">Aldehyde ferredoxin oxidoreductase</span>

In enzymology, an aldehyde ferredoxin oxidoreductase (EC 1.2.7.5) is an enzyme that catalyzes the chemical reaction

<span class="mw-page-title-main">Fosdenopterin</span> Medication

Fosdenopterin, sold under the brand name Nulibry, is a medication used to reduce the risk of death due to a rare genetic disease known as molybdenum cofactor deficiency type A.

<span class="mw-page-title-main">Molybdenum in biology</span> Use of molybdenum by organisms

Molybdenum is an essential element in most organisms. It is most notably present in nitrogenase which is an essential part of nitrogen fixation.

References

  1. 1 2 Daniels JN, Wuebbens MM, Rajagopalan KV, Schindelin H (January 2008). "Crystal structure of a molybdopterin synthase-precursor Z complex: insight into its sulfur transfer mechanism and its role in molybdenum cofactor deficiency". Biochemistry. 47 (2): 615–26. doi:10.1021/bi701734g. PMID   18092812.
  2. ↑ Wuebbens MM, Rajagopalan KV (April 2003). "Mechanistic and mutational studies of Escherichia coli molybdopterin synthase clarify the final step of molybdopterin biosynthesis". The Journal of Biological Chemistry. 278 (16): 14523–32. doi: 10.1074/jbc.m300453200 . PMID   12571226.
  3. ↑ Sloan J, Kinghorn JR, Unkles SE (February 1999). "The two subunits of human molybdopterin synthase: evidence for a bicistronic messenger RNA with overlapping reading frames". Nucleic Acids Research. 27 (3): 854–8. doi:10.1093/nar/27.3.854. PMC   148257 . PMID   9889283.
  4. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Rudolph, Michael J. and Wuebbens, Margot M. and Rajagopalan, K. V. and Schindelin, Hermann (2001). "Crystal structure of molybdopterin synthase and its evolutionary relationship to ubiquitin activation". Nature Structural Biology. 8 (1): 42–46. doi:10.1038/83034. PMID   11135669. S2CID   10494830.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  5. 1 2 3 4 5 6 7 8 Silke Leimkühler, Andrea Freuer, Jose ́ Angel Santamaria Araujo, K. V. Rajagopalan, and Ralf R. Mendel (2003). "Mechanistic Studies of Human Molybdopterin Synthase Reaction and Characterization of Mutants Identified in Group B Patients of Molybdenum Cofactor Deficiency". Journal of Biological Chemistry. 278 (28): 26127–26134. doi: 10.1074/jbc.M303092200 . PMID   12732628.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  6. 1 2 3 4 Stallmeyer, B., Schwarz, G., Schulze, J., Nerlich, A., Reiss, J., Kirsch, J., Mendel, R. R. (1999). "The neurotransmitter receptor-anchoring protein gephyrin reconstitutes molybdenum cofactor biosynthesis in bacteria, plants, and mammalian cells". Proceedings of the National Academy of Sciences of the United States of America. 96 (4): 1333–1338. Bibcode:1999PNAS...96.1333S. doi: 10.1073/pnas.96.4.1333 . PMC   15463 . PMID   9990024.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  7. 1 2 3 4 5 6 7 Reiss J (2000). "Genetics of molybdenum cofactor deficiency". Human Genetics. 106 (2): 157–163. doi:10.1007/s004390051023 (inactive 2024-11-02). PMID   10746556.{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)
  8. 1 2 Michael J. Rudolph, Margot M. Wuebbens, Oliver Turque, K. V. Rajagopalan, Hermann Schindelin (2003). "Structural Studies of Molybdopterin Synthase Provide Insights into Its Catalytic Mechanism". Journal of Biological Chemistry. 278 (16): 14514–14522. doi: 10.1074/jbc.M300449200 . PMID   12571227.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  9. 1 2 3 Wang, Chunyu and Xi, Jun and Begley, Tadhg P. and Nicholson, Linda K. (2001). "Solution structure of ThiS and implications for the evolutionary roots of ubiquitin". Nature Structural and Molecular Biology. 8 (1): 47–51. doi:10.1038/83041. PMID   11135670. S2CID   29632248.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  10. 1 2 Margot M. Wuebbens, K. V. Rajagopalan (1995). "Investigation of the Early Steps of Molybdopterin Biosynthesis in Escherichia coli through the Use of in Vivo Labeling Studies". Journal of Biological Chemistry. 270 (3): 1082–1087. doi: 10.1074/jbc.270.3.1082 . PMID   7836363.
  11. ↑ Gerrit Gutzke, Berthold Fischer, Ralf R. Mendel, Günter Schwarz (2001). "Thiocarboxylation of Molybdopterin Synthase Provides Evidence for the Mechanism of Dithiolene Formation in Metal-binding Pterins". Journal of Biological Chemistry. 276 (39): 36268–36274. doi: 10.1074/jbc.M105321200 . PMID   11459846.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  12. 1 2 3 4 J. Reiss, C. Dorche, B. Stallmeyer, R. R. Mendel, N. Cohen, M. T. Zabot (1999). "Human Molybdopterin Synthase Gene: Genomic Structure and Mutations in Molybdenum Cofactor Deficiency Type B". The American Journal of Human Genetics. 64 (3): 706–711. doi:10.1086/302296. PMC   1377787 . PMID   10053004.{{cite journal}}: CS1 maint: multiple names: authors list (link)
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.